731 Followers on Owler

Madrigal

is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of non-alcoholic steatohepatitis disease... Read more
OverviewCompetitorsFundingNews & Insights

Madrigal

is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of non-alcoholic steatohepatitis disease... Read more
Madrigal President & CEO: William Sibold

President & CEO

William Sibold

CEO Approval Rating

84/100

2011

PublicNASDAQMGDL

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
28362834 NAICS listing

Annual Revenue
$958.4M
Employees
376
Funding
$1.2B

News

Conference Presentation
Sep 08, 2025
Seeking Alpha
Madrigal Pharmaceuticals, Inc. (MDGL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Funding
Jul 22, 2025
GlobalNewswire
Madrigal received $500M in Post-IPO Debt Funding

Madrigal Competitors

1Intercept
2Gilead Sciences
3Galectin
4Galmed Pharmaceuticals
5Cirius Therapeutics
6PhaseBio
7Esperion
8Attune
9PanOptica
10Acer
Unlock 17 + competitors

Trending Companies